16th August 2022
16th August 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
16th August 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform, Accelerate Programs to the Clinic
2nd June 2022